Philip Morris International PM
equity
Price History
Time underwater
How far below its previous all-time high the price sat, each month. 0% means a new high.
Worst drawdown: −44%, peaking May 2017 and bottoming Dec 2018 — 87 months below the prior high before recovering.
DCA Backtest
- Invested
- $22,200
- Value today
- $51,342
- Return
- +131.3%
- Months invested
- 222
Scenarios
Inflation — the same contributions merely keeping pace with CPI would be $29,294 today, so the real (inflation-adjusted) return is +75.3%.
Lump sum instead — $22,200 all at once in Mar 2008: $81,720 (+268.1%) — lump sum came out ahead.
Worst timing — same monthly amount started at the all-time high (Jul 2026): $197.57 on $200 invested (-1.2%).
⚠ Price returns only — dividends are not included. This understates the true return of dividend-paying shares, and any comparison against crypto (which pays no dividends) is biased against equities by roughly the dividend yield, compounded.
If this saved you a spreadsheet — buy me a coffee.
Every start month at once
Each cell is the return-to-date of £/$/€100-a-month DCA started that month. Click a cell to load it in the backtest above. The ringed cell is the all-time-high start — the worst timing scenario.
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2008 | ||||||||||||
| 2009 | ||||||||||||
| 2010 | ||||||||||||
| 2011 | ||||||||||||
| 2012 | ||||||||||||
| 2013 | ||||||||||||
| 2014 | ||||||||||||
| 2015 | ||||||||||||
| 2016 | ||||||||||||
| 2017 | ||||||||||||
| 2018 | ||||||||||||
| 2019 | ||||||||||||
| 2020 | ||||||||||||
| 2021 | ||||||||||||
| 2022 | ||||||||||||
| 2023 | ||||||||||||
| 2024 | ||||||||||||
| 2025 | ||||||||||||
| 2026 |
About Philip Morris International
Philip Morris International Inc. (PMI) is a tobacco company, with products sold in over 180 countries. Marlboro is PMI’s most recognized brand, but in the last quarter of 2023, Iqos generated the greatest revenue. Philip Morris International is often referred to as one of the companies comprising Big Tobacco. The company ranked No. 121 in the 2025 Fortune 500 list of the largest US corporations by total revenue. (Wikipedia)
It's a listed company categorised under consumer staples and tobacco, with a market cap of about $290.2B.
It rates Medium-High Risk at 2.3/5, meaning real but ordinary risk — the kind most mainstream assets carry, with some factors scoring poorly.
What pushes the score up: earnings quality (4.0/5).
Scoring well: liquidity at 1.0/5.
Not yet researched: leverage / financial, concentration, governance. These are excluded from the score rather than guessed, so the real risk may be higher than what’s shown.
Ratings summarise sourced facts against fixed rules — not investment advice, and no substitute for your own diligence.
Risk Profile
- Annualised volatility (3yr)2/523.2
- Max drawdown from ATH2/544.3
- Beta vs S&P 5002/50.74
- Avg daily $ volume1/5933.4m
- Float % of shares outstandingnot yet researched
- Debt / equitynot yet researched
- Interest coverage (EBIT / interest)not yet researched
- 3yr EPS volatility4/549.9
- Largest customer, % of revenuenot yet researched
- Geographic revenue concentrationnot yet researched
- Board independence %not yet researched
- Share structurenot yet researched
- Litigation / audit historynot yet researched
- Sector regulatory exposure2/5moderate
Linked Assets
Same sector, or return-correlated — worth knowing what else might move if this one does.
- Altria MO+56% (moderate)same category: consumer staples, tobacco
- Coca-Cola Company (The) KO+57% (moderate)same category: consumer staples
- Colgate-Palmolive CL+54% (moderate)same category: consumer staples
- Kenvue KVUE+51% (moderate)same category: consumer staples
- Procter & Gamble PG+49% (moderate)same category: consumer staples
- Mondelez International MDLZ+47% (moderate)same category: consumer staples
- PepsiCo PEP+45% (moderate)same category: consumer staples
- Molson Coors Beverage Company TAP+43% (moderate)same category: consumer staples